Cell And Gene Articles, App Notes, Case Studies, & White Papers

1. Partner Case Study: Accelerating Gene Editing Manufacturing 10/28/2025

   Beam Therapeutics partnered with ElevateBio to manufacture BEAM-101, a novel base editing therapy for sickle cell disease, advancing rapid, high-quality production towards clinical trials.

2. How Automated NGS Solutions Advance Rare Disease Research 2/27/2026

   See how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.

3. A Scalable Manufacturing Platform For The Purification Of Stem Cell Derived Exosomes 5/16/2025

   EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored for therapeutic exosome programs and allow for maximum exosome recovery.

4. Essential Strategies For Effective Viral Clearance Studies In Biologics Manufacturing 4/2/2026

   Strengthen your viral safety strategy by applying science- and risk-based approaches to viral clearance planning, ensuring robust data, regulatory compliance, and patient protection.

5. Automated Fill And Finish For Cell Therapy 7/20/2026

   Automated fill-finish systems protect sensitive cell therapies using low-shear handling to maintain dose uniformity, cell viability, and process consistency across every batch.

6. Metabolic Phenotype Preservation And Suitability Of hMSCs Cultivated In Stirred Tank Bioreactors 7/9/2025

   Learn how researchers demonstrated scalable hADSC expansion in stirred-tank bioreactors using microcarriers, achieving metabolic stability and consistent growth for cell therapy applications.

7. Customer Story: Emergent BioSolutions Enhances Aseptic Filling Process 1/9/2026

   Upgrading outdated filling systems is essential for meeting future production demands and regulatory standards. Learn how one manufacturer modernized its approach to ensure compliance and efficiency.

8. Comparing In-Line Vs At-Line Variable Pathlength Tech For UF/DF 11/20/2025

   Discover how rapid amino acid profiling improves media insight, detects variability, and supports real-time optimization for stronger bioprocess control, as well as strategies to reduce risk.

9. 5 Operational Gaps To Avoid CGT Patient Risks 5/27/2026

   Examine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.

10. Supporting Global Approval Of A First-In-Class Gene Therapy For A Rare Genetic Disorder 5/27/2026

    Global approvals for a first-in-class gene therapy don’t happen by chance. See how adaptive oversight and inspection readiness kept a complex rare disease program moving forward.